Agomelatine May Alleviate Valproate Induced Hair Loss

References (1)

1. Atagun MI, Balaban OD, Lordoglu DY, Evren EC. Lithium and valproate may affect motor and sensory speed in patients with bipolar disorder. The Bulletin of Clinical Psychopharmacology 2013; 23:305-314. [CrossRef] 2. Atagun MI, Oral ET, Sevinc C. Polycystic kidney disease in a patient using lithium chronically. Turk Psikiyatri Derg 2013; 24:213. 3. Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin 2013; 31:67-73. [CrossRef] 4. Suzuki T, Koizumi J, Moroji T, Shiraishi H, Hori T, Baba A, Kawai N, Tada K. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 1992; 31:571–581. [CrossRef] 5. Stroud JD. Diagnosis and management of the hair loss patient. Cutis 1987; 40:272–276. 6. Wichniak A, Jarkiewicz M, Okruszek Ł, Wierzbicka 3, HolkaPokorska J, Rybakowski JK. Low risk for switch to mania during treatment with sleep promoting antidepressants. Pharmacopsychiatry 2015; 25:83-88. [CrossRef] 7. De Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010; 9:628-642. [CrossRef] 8. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol 2013; 79:591. [CrossRef] 9. Singh M, Jadhav HR. Melatonin: functions and ligands. Drug Discov Today 2014; 19:1410-1418. [CrossRef] 10. Fischer TW, Slominski A, Tobin DJ, Paus R. Melatonin and the hair follicle. J Pineal Res 2008; 44:1-5.